Initial characteristics and course of disease in patients with suspected COVID-19 managed in general practice: a prospective, multicentre cohort study

Objectives To describe and compare the initial clinical characteristics of a cohort of patients with suspected COVID-19 managed by general practitioners (GPs); to assess whether 3-month persistent symptoms were more frequent among confirmed cases than among no-COVID cases; and to identify factors predictive of persistent symptoms and adverse outcomes among confirmed cases. Design and setting A comparative, prospective, multicentre cohort study in primary care in the Paris region of France. Participants 521 patients aged ≥18 with suspected COVID-19 were enrolled between March and May 2020. Outcome measures Initial symptoms, COVID-19 status, persistent symptoms 3 months after inclusion and a composite criterion for potentially COVID-19-related events (hospitalisation, death, emergency department visits). The final COVID-19 status (‘confirmed’, ‘no-COVID’ and ‘uncertain’ cases) was determined by the GP after the receipt of the laboratory test results. Results 516 patients were analysed; 166 (32.2%) were classified into the ‘confirmed COVID’ group, 180 (34.9%) into the ‘no-COVID’ group and 170 (32.9%) in the ‘uncertain COVID’ group. Confirmed cases were more likely to have persistent symptoms than no-COVID cases (p=0.09); initial fever/feeling feverish and anosmia were independently associated with persistent symptoms. At 3 months, we observed 16 (9.8%) COVID-19-related hospital admissions, 3 (1.8%) intensive care unit admissions, 13 (37.1%) referrals to an emergency department and no death. Age >70 and/or at least one comorbidity (OR 6.53; 95% CI 1.13–37.84; p=0.036), abnormalities in a lung examination (15.39; 95% CI 1.61–146.77; p=0.057) and two or more systemic symptoms (38.61; 95% CI 2.30–647.40; p=0.011) were associated with the composite criterion. Conclusions Although most patients with COVID-19 in primary care had mild disease with a benign course, almost one in six had persistent symptoms at 3 months. These symptoms were more frequent in the ‘confirmed COVID’ group. Our findings need to be confirmed in a prospective study with longer follow-up.

[1]  A. Agarwal,et al.  Correction: Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review , 2022, PloS one.

[2]  S. Baggio,et al.  One‐year persistent symptoms and functional impairment in SARS‐CoV‐2 positive and negative individuals , 2022, Journal of internal medicine.

[3]  G. Severi,et al.  Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. , 2021, JAMA internal medicine.

[4]  A. Ramalho,et al.  COVID-19 patients followed in Portuguese Primary Care: a retrospective cohort study based on the national case series. , 2021, Family practice.

[5]  I. Guessous,et al.  Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting , 2021, Annals of Internal Medicine.

[6]  N. Prado,et al.  Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate. , 2021, Ciencia & saude coletiva.

[7]  S. Rosenkranz,et al.  Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study , 2021, The Lancet Regional Health - Europe.

[8]  A. Mebazaa,et al.  Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study , 2021, Annals of intensive care.

[9]  A. Dechartres,et al.  Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study , 2021, Clinical Microbiology and Infection.

[10]  B. Guery,et al.  Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study , 2021, Journal of General Internal Medicine.

[11]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[12]  David A. Drew,et al.  Attributes and predictors of long COVID , 2021, Nature Medicine.

[13]  Devy M. Emperador,et al.  Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 , 2021, The Cochrane database of systematic reviews.

[14]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[15]  M. Schuers,et al.  How GPs adapted their practices and organisations at the beginning of COVID-19 outbreak: a French national observational survey , 2020, BMJ Open.

[16]  H. Peckham,et al.  Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission , 2020, Nature Communications.

[17]  S. Merler,et al.  Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  N. Washington,et al.  Long-term COVID-19 symptoms in a large unselected population , 2020 .

[19]  C. van Weel,et al.  COVID-19 and primary care in six countries , 2020, BJGP open.

[20]  S. Unal,et al.  Out-patient management of patients with COVID-19 on home isolation. , 2020, Le infezioni in medicina.

[21]  S. Zayet,et al.  Sensibilité, spécificité et valeurs prédictives des signes fonctionnels de l’infection par SARS-CoV-2 , 2020, Médecine et Maladies Infectieuses.

[22]  D. Morquin,et al.  Dépistage de la COVID-19 : valeurs diagnostiques d’une anosmie rapportée ou objectivée par un test clinique , 2020, Médecine et Maladies Infectieuses.

[23]  M. Nawaz,et al.  Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study , 2020, Journal of medical microbiology.

[24]  L. Goix,et al.  Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study , 2020, Internal and Emergency Medicine.

[25]  Soumitra Sengupta,et al.  Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series , 2020, BMJ.

[26]  P. Horby,et al.  Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study , 2020, BMJ.

[27]  Bernard Harmegnies,et al.  Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019 , 2020, Journal of internal medicine.

[28]  Leonardo Ferreira Fontenelle,et al.  What is the role of Primary Health Care in the COVID-19 pandemic? , 2020, Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil.

[29]  E. Pham,et al.  High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California , 2020, Gastroenterology.

[30]  R. Carlier,et al.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.

[31]  John Bradley,et al.  Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[32]  T. Greenhalgh,et al.  Covid-19: a remote assessment in primary care , 2020, BMJ.

[33]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[34]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[35]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[36]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[37]  Mirjam Moerbeek,et al.  Multilevel Analysis : Techniques and Applications, Third Edition , 2017 .

[38]  J. Brown.  Patient-centred medicine: Transforming the clinical method , 1998 .

[39]  Addendum A L’AVIS.  Haut Conseil de la santé publique , 2011 .

[40]  J. Hox.  Multilevel analysis: Techniques and applications, 2nd ed. , 2010 .